DRAI yields 1.59% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, DRAI + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DRAI + MRK for your $10,000?
DRAI aims for long-term capital appreciation by holding 10-20 ETF positions across a variety of asset classes including US equities, gold, fixed-income securities, and more. The fund uses an AI model trained on historical pricing data to predict short-term market trends and volatility, which influences 70% of its asset selections. This is complemented by a macroeconomic model analyzing data like unemployment insurance applications and interest rate spreads to inform long-term outlooks. Combined, they make up the funds proprietary AI system called the Draco Model. In bearish markets, DRAI leans towards US treasury bonds and inverse ETFs, in bullish markets, it favors US equities and leveraged ETFs. The fund continually rebalances based on daily market conditions and has mechanisms to provide downside protection but may experience increased volatility due to leveraged investments. The Funds sub-adviser has the discretion to override the AI model in extreme circumstances.
Full DRAI Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.